Clinical trial
Feasibility Study of the Intravascular Ventricular Assist System (iVAS)
NCT02645539 · NuPulseCV, Industry · Unknown status
Key facts
| NCT number | NCT02645539 |
|---|---|
| Title | Feasibility Study of the Intravascular Ventricular Assist System (iVAS) |
| Official title | A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study |
| Lead sponsor | NuPulseCV, Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Heart Failure NYHA Class III, Heart Failure NYHA Class IV |
| Intervention type | Device |
| Interventions | intravascular ventricular assist system (iVAS) |
| Enrollment | 100 |
| Start date | Apr 1, 2016 |
| Primary completion | Jul 1, 2020 |
| Completion | Dec 1, 2020 |
| First posted | Jan 1, 2016 |
| Last update posted | Nov 13, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: